EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ZeCardioAI: combining zebrafish, AI, and xAI for an in-depth cardiac phenotyping platform

Ferran Arqué iD, Carole Jung iD, Beatriz Muriel-Moreno iD, Laura López-Blanch iD, Eduardo Saman iD, Davide D'Amico iD, Javier Terriente iD, Paula Petrone iD, Sylvia Dyballa iD

Briefings in Bioinformatics · 01.03.2026 · 27 (2)

DOI: 10.1093/bib/bbag197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 25.04.2026. Verfasst von Ferran Arqué und 8 weiteren Autor:innen. Beteiligte Einrichtung: Early Drug Discovery Department, ZeCardio Therapeutics, Carrer de Laureà Miró, 408, 410, 08980 Barcelona, Spain. Hauptthemen laut MEDLINE: Zebrafish, Artificial Intelligence, Heart, Deep Learning. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NextGenEU programme "Artificial Intelligence and Other Digital Technologies to Drive Their Integration into Value Chains", Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) integrated with high-throughput assays offers a powerful route to accelerate discovery in relevant biological models. Functional cardiac imaging is a prime application, where deep learning (DL) and explainable AI (xAI) can overcome limitations of traditional phenotyping methods, such as manual analysis, subjective interpretation, and low scalability. In cardiovascular research, the zebrafish model is highly valuable due to its translational relevance and accessibility for high-throughput applications. Here, we present ZeCardioAI, a computational platform combining zebrafish experimental advantages with DL and xAI methodologies. The platform automatically extracts comprehensive cardiac phenotypes from live imaging, achieving high precision while maintaining interpretability, critical for mechanistic insight and translational validation. ZeCardioAI, when applied to zebrafish models of dilated and hypertrophic cardiomyopathy (CM), detected subtle yet clinically relevant phenotypic differences. Machine learning classifiers achieved robust separation of disease from healthy phenotypes, and xAI revealed discriminative features aligning with established clinical markers. Our developments should prove valuable in addressing the unmet medical need in CMs to find new, specific treatments. The platform’s modular architecture supports future adaptation to diverse disease contexts beyond CMs, enabling large-scale, fully automated phenotyping at a throughput unattainable by manual approaches. ZeCardioAI establishes a new standard for AI-powered biological research, offering transformative potential for accelerating drug discovery, advancing precision medicine approaches, and deepening fundamental understanding of complex biological systems across multiple therapeutic areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishArtificial IntelligenceHeartDeep LearningCardiomyopathy, HypertrophicAnimalsPhenotypeHumansDisease Models, AnimalMachine Learning

Stichwörter der Autor:innen

artificial intelligencecardiomyopathyexplainable AImachine learningphenotypingzebrafish

Autor:innen und Institutionen

  • Early Drug Discovery Department, ZeCardio Therapeutics, Carrer de Laureà Miró, 408, 410, 08980 Barcelona, Spain.
  • Technology and Innovation Department, ZeClinics SL, Carrer de Laureà Miró, 408, 410, 08980 Barcelona, Spain.
  • Biomedical Data Science Group, Institut de Salut Global de Barcelona (ISGlobal), Carrer del Doctor Aiguader, 88, 08003 Barcelona, Spain.
  • Life Sciences - Digital Health Unit, Barcelona Supercomputing Center (BSC-CNS), Plaça d'Eusebi Güell, 1-3, 08034 Barcelona, Spain.

ORCID-Profile: Ferran Arqué, Carole Jung, Beatriz Muriel-Moreno, Laura López-Blanch, Eduardo Saman, Davide D'Amico, Javier Terriente, Paula Petrone, Sylvia Dyballa

Förderung

  • NextGenEU programme "Artificial Intelligence and Other Digital Technologies to Drive Their Integration into Value Chains"
  • Ministerio de Ciencia e Innovación
  • Agencia Estatal de Investigación
  • Ayudas para Doctorados Industriales
  • NextGenEU programme “Artificial Intelligence and Other Digital Technologies to Drive Their Integration into Value Chains”

Zitieren

APA

Arqué, F., Jung, C., Muriel-Moreno, B., López-Blanch, L., Saman, E., D'Amico, D., Terriente, J., Petrone, P., & Dyballa, S. (2026). ZeCardioAI: combining zebrafish, AI, and xAI for an in-depth cardiac phenotyping platform. Briefings in Bioinformatics, 27(2). https://doi.org/10.1093/bib/bbag197

Vancouver

Arqué F, Jung C, Muriel-Moreno B, López-Blanch L, Saman E, D'Amico D, et al. ZeCardioAI: combining zebrafish, AI, and xAI for an in-depth cardiac phenotyping platform. Briefings in Bioinformatics. 2026;27(2). doi:10.1093/bib/bbag197

BibTeX
@article{Arqu2026,
  author = {Arqué, Ferran and Jung, Carole and Muriel-Moreno, Beatriz and López-Blanch, Laura and Saman, Eduardo and D'Amico, Davide and Terriente, Javier and Petrone, Paula and Dyballa, Sylvia},
  title = {ZeCardioAI: combining zebrafish, AI, and xAI for an in-depth cardiac phenotyping platform},
  journal = {Briefings in Bioinformatics},
  year = {2026},
  volume = {27},
  number = {2},
  doi = {10.1093/bib/bbag197}
}
Kostenlos starten →